X-45063449-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001291415.2(KDM6A):c.1711C>T(p.Arg571*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001291415.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Kabuki syndrome 2Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KDM6A | NM_001291415.2 | c.1711C>T | p.Arg571* | stop_gained | Exon 17 of 30 | ENST00000611820.5 | NP_001278344.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KDM6A | ENST00000611820.5 | c.1711C>T | p.Arg571* | stop_gained | Exon 17 of 30 | 1 | NM_001291415.2 | ENSP00000483595.2 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.1555C>T (p.R519*) alteration, located in exon 16 (coding exon 16) of the KDM6A gene, consists of a C to T substitution at nucleotide position 1555. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 519. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration has been reported in the hemizygous state in a male patient with Kabuki syndrome (Miyake, 2013). Based on the available evidence, this alteration is classified as pathogenic. -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23076834) -
Kabuki syndrome 2 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at